Motif Neurotech just got FDA approval to trial a tiny brain implant for treating depression, and the whole thing can be implanted in just 20 minutes.
Digital Camera World on MSN
This 2,500-year-old photo technique lets you shoot without a camera lens – here's how to do it
No lens required: how to shoot stunning, dreamlike images with a DIY pinhole camera ...
The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) charges a much lower expense ratio and offers a higher dividend yield than the iShares Russell 2000 Value ETF (NYSEMKT:IWN). IWN delivered a ...
Vanguard Small-Cap ETF charges half the expense ratio of iShares Core S&P Small-Cap ETF, but both are extremely low-cost. IJR is slightly more concentrated and tilts more toward financials, while VB ...
The adage that “elephants don’t gallop” – as the late investor Jim Slater put it – has become accepted wisdom. Yet for many years, large-cap stocks have comfortably outstripped small-cap stocks. The ...
Two Average Gamers on MSN
How I make product demos that don't look like garbage
Tired of screen recordings that look like they were filmed on a potato? Here's the tool that makes my demos look pro with ...
Thanks to inflation, $100 doesn't sound like much these days, but there's another way for investors to look at that amount. Consider it as a seed to be planted and, when tended to, one that will grow ...
Small-cap ETFs are goldmines that contain some of the most promising opportunities. Instead of digging through small-cap ETFs, you can buy shares in the funds for diversified exposure. Are you ahead, ...
Three weeks ago, I wondered if the leadership rotation this year toward small- and micro-cap stocks would persist. Leading the charge higher this year: micro caps - IWC - which is still running hot in ...
Small-cap stocks are on a tear: The Morningstar US Small Cap Index is outperforming both the Morningstar US Large Cap Index and the broad-based Morningstar US Market Index by a healthy margin over the ...
Joseph Lucosky is the Managing Partner of Lucosky Brookman, a leading law firm in the world of microcap IPOs and Nasdaq/NYSE listings. On the surface, the 2025 micro-cap IPO market was more active ...
With an average annual return of 12.4%, the Oberweis Micro-Cap Fund is the fifth-best-performing US stock fund of the past 25 years. The fund uses a strategy based on an investing phenomenon called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results